Migraine Headache News & Migraine Treatment Articles

Woman with headache, computer illustration.

Galcanezumab Reduced Migraine Days After Prior Preventive Medication Failure

Galcanezumab effectively treats episodic or chronic migraine after multiple standard of care preventive medication failures.

Rimegepant Under Review for Migraine Prevention

The Food and Drug Administration has accepted for review the supplemental New Drug Application for rimegepant (Nurtec™ ODT; Biohaven) for the preventive treatment of migraine.

Neurologic Manifestations Seen in Most Hospitalized With COVID-19

Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.

Cefaly Dual Migraine Treatment Now Available Over-the-Counter

Previously, the external trigeminal nerve stimulator was only available with a prescription.

Efficacy of Repetitive Intravenous Dihydroergotamine for Pediatric Refractory Migraine

Repetitive intravenous dihydroergotamine may be an effective therapy for children with status migrainous or chronic migraine, but without lasting benefit.

Timolol Eyedrops Evaluated for Acute Migraine Treatment

During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops.

Higher Odds of Migraines Seen Among Sexual Minorities

Migraine is more common among sexual-minority groups than individuals identifying as exclusively heterosexual.

Red Flags of Past Medical History Common in Patients With COVID-19 and Headache

While there was no universal one, red flags concerning prior medical history were present in almost all patients with COVID-19 who developed headache.